OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
18
Results
Show all
Save search
Copy query
Show results for
Unknown
(18)
Publication Date
Release Date
2021
(4)
2019
(3)
2022
(2)
2020
(2)
2016
(2)
2015
(2)
2023
(1)
2018
(1)
2012
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer.
Not available
S-EPMC4669588
|
biostudies-literature
Cite
MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet.
Not available
S-EPMC4526192
|
biostudies-literature
Cite
The KRAS
G12C
Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients.
Not available
S-EPMC6954325
|
biostudies-literature
Cite
Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancer.
Not available
S-EPMC9184270
|
biostudies-literature
Cite
JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted
Listeria monocytogenes
-Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 Studies.
Not available
S-EPMC8474274
|
biostudies-literature
Cite
Searching for evidence in public health emergencies: a white paper of best practices.
Not available
S-EPMC10259619
|
biostudies-literature
Cite
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer.
Not available
S-EPMC6484853
|
biostudies-literature
Cite
Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes.
Not available
S-EPMC4914052
|
biostudies-literature
Cite
CLIN-ONGOING CLINICAL TRIALS
Not available
S-EPMC3488786
|
biostudies-literature
Cite
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
Not available
S-EPMC9321995
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets